Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Other

219: An Interview With Dr. Natalie Truba on the Psychological Aspects of Gene Therapy

 April 7, 2026

Rare Disease Audio

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews pediatric psychologist Natalie Truba, PhD, on the psychological aspects of gene therapy in neuromuscular disease.

OtherGene Therapy PlatformRead full story

Post navigation

Gilead strikes again, penning $5bn deal to buy Tubulis →
← Gilead Swallows Another Partner, Paying up to $5B for ADC Specialist Tubulis

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com